266 related articles for article (PubMed ID: 21862418)
1. Inverse-planned gynecologic high-dose-rate interstitial brachytherapy: clinical outcomes and dose--volume histogram analysis.
Thibault I; Lavallée MC; Aubin S; Laflamme N; Vigneault E
Brachytherapy; 2012; 11(3):181-91. PubMed ID: 21862418
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes of high-dose-rate interstitial gynecologic brachytherapy using real-time CT guidance.
Lee LJ; Damato AL; Viswanathan AN
Brachytherapy; 2013; 12(4):303-10. PubMed ID: 23491023
[TBL] [Abstract][Full Text] [Related]
3. Predictors of toxicity after image-guided high-dose-rate interstitial brachytherapy for gynecologic cancer.
Lee LJ; Viswanathan AN
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1192-7. PubMed ID: 22592049
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional image-based high-dose-rate interstitial brachytherapy for vaginal cancer.
Beriwal S; Rwigema JC; Higgins E; Kim H; Houser C; Sukumvanich P; Olawaiye A; Richard S; Kelley JL; Edwards RP; Krivak TC
Brachytherapy; 2012; 11(3):176-80. PubMed ID: 21665553
[TBL] [Abstract][Full Text] [Related]
5. Management of Bartholin's gland carcinoma using high-dose-rate interstitial brachytherapy boost.
Thibault I; Lavallée MC; Aubin S; Jain S; Laflamme N; Vigneault É
Brachytherapy; 2013; 12(5):500-7. PubMed ID: 23406985
[TBL] [Abstract][Full Text] [Related]
6. High-dose-rate interstitial brachytherapy for gynecologic malignancies.
Beriwal S; Bhatnagar A; Heron DE; Selvaraj R; Mogus R; Kim H; Gerszten K; Kelley J; Edwards RP
Brachytherapy; 2006; 5(4):218-22. PubMed ID: 17118313
[TBL] [Abstract][Full Text] [Related]
7. High-dose rate brachytherapy using inverse planning simulated annealing for locoregionally advanced cervical cancer: a clinical report with 2-year follow-up.
Kim DH; Wang-Chesebro A; Weinberg V; Pouliot J; Chen LM; Speight J; Littell R; Hsu IC
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1329-34. PubMed ID: 19409728
[TBL] [Abstract][Full Text] [Related]
8. Inversely and adaptively planned interstitial brachytherapy: A single implant approach.
Hanania AN; Myers P; Yoder AK; Bulut A; Henry Yu Z; Eraj S; Bowers J; Bonnen MD; Echeverria A; Hall TR; Anderson ML; Ludwig M
Gynecol Oncol; 2019 Feb; 152(2):353-360. PubMed ID: 30449720
[TBL] [Abstract][Full Text] [Related]
9. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
[TBL] [Abstract][Full Text] [Related]
10. High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds.
Grills IS; Martinez AA; Hollander M; Huang R; Goldman K; Chen PY; Gustafson GS
J Urol; 2004 Mar; 171(3):1098-104. PubMed ID: 14767279
[TBL] [Abstract][Full Text] [Related]
11. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
12. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
[TBL] [Abstract][Full Text] [Related]
13. Treatment of locally advanced vaginal cancer with radiochemotherapy and magnetic resonance image-guided adaptive brachytherapy: dose-volume parameters and first clinical results.
Dimopoulos JC; Schmid MP; Fidarova E; Berger D; Kirisits C; Pötter R
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1880-8. PubMed ID: 21868174
[TBL] [Abstract][Full Text] [Related]
14. High-dose-rate interstitial computed tomography-based brachytherapy for the treatment of cervical cancer: early results.
Kannan N; Beriwal S; Kim H; Houser C; Mogus R; Sukumvanich P; Olawaiye AB; Richard S; Kelley JL; Edwards RP; Krivak TC
Brachytherapy; 2012; 11(5):408-12. PubMed ID: 22513106
[TBL] [Abstract][Full Text] [Related]
15. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
[TBL] [Abstract][Full Text] [Related]
16. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
[TBL] [Abstract][Full Text] [Related]
17. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
[TBL] [Abstract][Full Text] [Related]
18. A new model using number of needles and androgen deprivation to predict chronic urinary toxicity for high or low dose rate prostate brachytherapy.
Vargas C; Ghilezan M; Hollander M; Gustafson G; Korman H; Gonzalez J; Martinez A
J Urol; 2005 Sep; 174(3):882-7. PubMed ID: 16093980
[TBL] [Abstract][Full Text] [Related]
19. CT-based interstitial brachytherapy in advanced gynecologic malignancies: outcomes from a single institution experience.
D'Souza D; Wiebe E; Patil N; Sugimoto A; Prefontaine M; Aulakh S; Whiston F; Stitt L; Surry K
Brachytherapy; 2014; 13(3):225-32. PubMed ID: 24613570
[TBL] [Abstract][Full Text] [Related]
20. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
Ferrigno R; Nishimoto IN; Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1108-16. PubMed ID: 15990016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
